Fermenta Biotech Board of Directors

Get the latest insights into the leadership at Fermenta Biotech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Pradeep M Chandan Chairman & Ind.Dire (Non-Exe)
Mr. Krishna Datla Exe.Vice Chairman & Whole Time Director
Mr. Prashant Nagre Managing Director
Mr. Satish Varma Executive Director
Ms. Anupama Datla Desai Executive Director
Ms. Rajeshwari Datla Non Executive Director
Mr. Pramod Kasat Ind. Non-Executive Director
Ms. Rajashri Ojha Ind. Non-Executive Director
Mr. Ramanand Mundkur Independent Director

Fermenta Biotech Share price

FERMENTA

333.2

5.45 (1.66%)
Last updated on 4 Sep, 2025 | 15:46 IST
BUYSELL
Today's High

334.85

Today's Low

325.05

52 Week Low

219.00

52 Week High

449.00

The current prices are delayed, login to your account for live prices

Fermenta Biotech FAQs

The board at Fermenta Biotech consists of experienced professionals, including Mr. Pradeep M Chandan , Mr. Krishna Datla , and others, overseeing the company’s strategic and corporate governance.

Directors at Fermenta Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Pradeep M Chandan is the current chairman at Fermenta Biotech.

Executive directors at Fermenta Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Fermenta Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Fermenta Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.